Research any topic before you write.
Find related topics. | Discover entities. | See connections. | Build a topical map.
Cyclophosphamide (CP), also known as cytophosphane among other names, is a medication used as chemotherapy and to suppress the immune system. As chemotherapy it is used to treat lymphoma, multiple myeloma, leukemia, ovarian cancer, breast cancer, small cell lung cancer, neuroblastoma, and sarcoma. As an immune suppressor it is used in nephrotic syndrome…
History, Community, Culture & Applications
Explore the main themes, entities and connections around Cyclophosphamide. Start with the topic map, then use the sections below for research and deeper semantic analysis.
Start with a few of the strongest sections from the source topic. These are research directions, not a list of keywords you must use.
High-confidence facts extracted from structured source data. Use them as anchors for further research.
Browse the full topic structure. Each item opens a new analysis centered on that subject.
Deeper signals for content research, entity SEO and topical coverage. The plain-language headings explain what each technical view is useful for.
See the strongest relationship patterns around the current topic before diving into the raw triples.
Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.
used cancer effects bladder mustard cell leukemia treatment side may drug dose use include acrolein infertility chemotherapy active metabolites cells
| Subject | Predicate | Object | Confidence | Src |
|---|---|---|---|---|
| Cyclophosphamide | 3D model (JSmol) | Interactive image | 1.00 | infobox |
| Cyclophosphamide | AHFS/Drugs.com | Monograph | 1.00 | infobox |
| Cyclophosphamide | ATC code | L01AA01 (WHO) | 1.00 | infobox |
| Cyclophosphamide | Bioavailability | >75% (by mouth) | 1.00 | infobox |
| Cyclophosphamide | CAS Number | 50-18-0 Y | 1.00 | infobox |
| Cyclophosphamide | ChEBI | CHEBI:4027 Y | 1.00 | infobox |
| Cyclophosphamide | ChEMBL | ChEMBL88 Y | 1.00 | infobox |
| Cyclophosphamide | ChemSpider | 2804 Y | 1.00 | infobox |
| Cyclophosphamide | CompTox Dashboard (EPA) | DTXSID5020364 | 1.00 | infobox |
| Cyclophosphamide | DrugBank | DB00531 Y | 1.00 | infobox |
| Cyclophosphamide | ECHA InfoCard | 100.000.015 | 1.00 | infobox |
| Cyclophosphamide | Elimination half-life | 3–12 hours | 1.00 | infobox |
| Cyclophosphamide | Excretion | Kidney | 1.00 | infobox |
| Cyclophosphamide | Formula | C7H15Cl2N2O2P | 1.00 | infobox |
| Cyclophosphamide | KEGG | D07760 Y | 1.00 | infobox |
| Cyclophosphamide | Legal status | AU: S4 (Prescription only) | 1.00 | infobox |
| Cyclophosphamide | Legal status | CA: ℞-only | 1.00 | infobox |
| Cyclophosphamide | Legal status | UK: POM (Prescription only) | 1.00 | infobox |
| Cyclophosphamide | Legal status | US: ℞-only | 1.00 | infobox |
| Cyclophosphamide | Legal status | In general: ℞ (Prescription only) | 1.00 | infobox |
| Cyclophosphamide | MedlinePlus | a682080 | 1.00 | infobox |
| Cyclophosphamide | Melting point | 2 °C (36 °F) | 1.00 | infobox |
| Cyclophosphamide | Metabolism | Liver | 1.00 | infobox |
| Cyclophosphamide | Molar mass | 261.08 g·mol−1 | 1.00 | infobox |
| Cyclophosphamide | Pregnancy category | AU: D | 1.00 | infobox |
| Cyclophosphamide | Pronunciation | /ˌsaɪkloʊˈfɒsfəˌmaɪd, -lə-/ | 1.00 | infobox |
| Cyclophosphamide | Protein binding | >60% | 1.00 | infobox |
| Cyclophosphamide | PubChem CID | 2907 | 1.00 | infobox |
| Cyclophosphamide | Routes of administration | By mouth, by injection into a vein | 1.00 | infobox |
| Cyclophosphamide | Trade names | Lyophilized Cytoxan, Endoxan, Cytoxan, Neosar, Procytox, Revimmune, Cycloblastin | 1.00 | infobox |
These clusters group vocabulary that occurs around closely connected concepts in the source material.
Bridges can reveal useful research angles that are easy to miss in a flat list of related terms.